Telix Pharmaceuticals Limited

NASDAQ:TLX USA Biotechnology

Market Cap

$3.08 Billion

Market Cap Rank

#4290 Global

#2709 in USA

Share Price

$9.20

Change (1 day)

+2.56%

52-Week Range

$6.41 - $19.22

All Time High

$39.51

Telix Pharmaceuticals Limited - Asset Resilience Ratio

Latest as of June 2018: 32.29%

Telix Pharmaceuticals Limited (TLX) has an Asset Resilience Ratio of 32.29% as of June 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$15.67 Million

Cash + Short-term Investments

Total Assets

$48.51 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Telix Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Telix Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$15.67 Million	32.29%
Total Liquid Assets	$15.67 Million	32.29%

Asset Resilience Insights

Very High Liquidity: Telix Pharmaceuticals Limited maintains exceptional liquid asset reserves at 32.29% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.